1.0Pharma Trendhttps://pharma-trend.com/enBusiness Wirehttps://pharma-trend.com/en/author/business/Reditus to Cease Operations - Pharma Trendrich600338<blockquote class="wp-embedded-content" data-secret="GqjPJC9i8I"><a href="https://pharma-trend.com/en/reditus-to-cease-operations/">Reditus to Cease Operations</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://pharma-trend.com/en/reditus-to-cease-operations/embed/#?secret=GqjPJC9i8I" width="600" height="338" title="“Reditus to Cease Operations” — Pharma Trend" data-secret="GqjPJC9i8I" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://pharma-trend.com/en/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
PEKIN, Ill.–(BUSINESS WIRE)–Reditus Laboratories will be ceasing all laboratory testing as of the close of business on November 4, 2022, and in the coming months expects to liquidate its assets in an orderly fashion and dissolve as an entity, subject to court approvals. A previously reported dispute between the owners of Reditus is ongoing, and ... [Read more...]